Life Stem Genetics Stock

Life Stem Genetics EBIT per Share

EBIT per Share of Life Stem Genetics (LIFS) as of Aug 16, 2026.

EBIT per Share

-0.00USD

YoY

-74.16%

Last updated:

EBIT per Share of Life Stem Genetics is 2026 -0.00 USD. EBIT per Share of Life Stem Genetics was 2025 -0.00 USD. It decreases by -74.16% higher compared to the previous year.
Access this data via the Eulerpool API

Life Stem Genetics Stock analysis

What does Life Stem Genetics do? Life Stem Genetics Inc is a company specializing in regenerative medicine, specifically in the manufacturing and application of stem cell therapies. It was founded in 2012 by experienced scientists and entrepreneurs and has since become a leading provider of stem cell treatments. The business model of Life Stem Genetics is based on the development and application of stem cell therapies that aim to regenerate diseased or injured tissues and organs. These therapies are utilized by specialized doctors and clinics worldwide to treat a variety of conditions and injuries, including degenerative diseases such as arthritis, osteoporosis, and Alzheimer's, as well as joint, muscle, and bone injuries. The company operates in various sectors, each focusing on different aspects of regenerative medicine. One of these sectors is the research of new stem cell therapies and technologies, aiming to improve the effectiveness and efficiency of treatments. This includes the identification of new types of stem cells, the development of new cultivation techniques, and the optimization of procedures for stem cell transplantation. Another sector of Life Stem Genetics is the production of stem cell products that can be used by doctors and clinics for patient treatment. This includes stem cell preparations for injection into the bloodstream or tissues, as well as freeze & thaw preparations used for long-term storage of stem cells. In addition to research and production of stem cell therapies, Life Stem Genetics also offers consulting services for doctors and clinics interested in utilizing stem cell treatments. This includes training and workshops on stem cell therapy, support in setting up stem cell clinics, and expert opinions on specific application areas. The products of Life Stem Genetics include various stem cell therapies tailored to the treatment of specific diseases and injuries. For example, the company offers stem cell therapies for the treatment of arthritis, spinal injuries, and diabetes. Furthermore, the company has also developed stem cell treatments specifically targeting the regeneration of skin tissue and hair follicles. Overall, Life Stem Genetics is an innovative company in the field of regenerative medicine, contributing to the improvement of patients' lives worldwide through its research, production, and application of stem cell therapies. With its diverse product portfolio and extensive expertise in the selection and use of stem cells, the company is a significant player in this field and will continue to play an important role in the development of new therapies and treatment options in the future. Life Stem Genetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Life Stem Genetics stock

On Eulerpool you can find the complete historical development of EBIT per Share Life Stem Genetics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

Income Statement — Life Stem Genetics

All Key Metrics — Life Stem Genetics